200 related articles for article (PubMed ID: 18594535)
1. DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma.
Seng TJ; Currey N; Cooper WA; Lee CS; Chan C; Horvath L; Sutherland RL; Kennedy C; McCaughan B; Kohonen-Corish MR
Br J Cancer; 2008 Jul; 99(2):375-82. PubMed ID: 18594535
[TBL] [Abstract][Full Text] [Related]
2. Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer.
Pastuszak-Lewandoska D; Kordiak J; Antczak A; Migdalska-Sęk M; Czarnecka KH; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska-Senderowska D; Brzeziańska-Lasota E
Med Oncol; 2016 Jul; 33(7):75. PubMed ID: 27287342
[TBL] [Abstract][Full Text] [Related]
3. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
4. Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis.
Antczak A; Migdalska-Sęk M; Pastuszak-Lewandoska D; Czarnecka K; Nawrot E; Domańska D; Kordiak J; Górski P; Brzeziańska E
Med Oncol; 2013 Jun; 30(2):532. PubMed ID: 23504373
[TBL] [Abstract][Full Text] [Related]
5. [DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer].
Song H; Yi J; Zhang Y; Wang R; Chen L
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):233-8. PubMed ID: 21426665
[TBL] [Abstract][Full Text] [Related]
6. Small suitability of the DLEC1, MLH1 and TUSC4 mRNA expression analysis as potential prognostic or differentiating markers for NSCLC patients in the Polish population.
Kordiak J; Czarnecka KH; Pastuszak-Lewandoska D; Antczak A; Migdalska-Sęk M; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz J; Brzeziańska-Lasota E
J Genet; 2017 Jun; 96(2):227-234. PubMed ID: 28674222
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer.
Hitchins MP; Lin VA; Buckle A; Cheong K; Halani N; Ku S; Kwok CT; Packham D; Suter CM; Meagher A; Stirzaker C; Clark S; Hawkins NJ; Ward RL
Cancer Res; 2007 Oct; 67(19):9107-16. PubMed ID: 17909015
[TBL] [Abstract][Full Text] [Related]
8. Methylation analysis for multiple gene promoters in non-small cell lung cancers in high indoor air pollution region in China.
Huang X; Wu C; Fu Y; Guo L; Kong X; Cai H
Bull Cancer; 2018 Sep; 105(9):746-754. PubMed ID: 30126609
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of DNA repair genes MLH1 and MSH2 in adenocarcinomas and squamous cell carcinomas of the lung.
Gomes A; Reis-Silva M; Alarcão A; Couceiro P; Sousa V; Carvalho L
Rev Port Pneumol; 2014; 20(1):20-30. PubMed ID: 24360395
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR
Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559
[TBL] [Abstract][Full Text] [Related]
11. Methylation profiling of archived non-small cell lung cancer: a promising prognostic system.
Safar AM; Spencer H; Su X; Coffey M; Cooney CA; Ratnasinghe LD; Hutchins LF; Fan CY
Clin Cancer Res; 2005 Jun; 11(12):4400-5. PubMed ID: 15958624
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer.
Choi N; Son DS; Song I; Lee HS; Lim YS; Song MS; Lim DS; Lee J; Kim H; Kim J
Int J Cancer; 2005 Jul; 115(4):575-81. PubMed ID: 15700308
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
[TBL] [Abstract][Full Text] [Related]
14. RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer.
Dutkowska A; Antczak A; Pastuszak-Lewandoska D; Migdalska-Sek M; Czarnecka KH; Górski P; Kordiak J; Nawrot E; Brzeziańska-Lasota E
Adv Exp Med Biol; 2016; 878():29-38. PubMed ID: 26453065
[TBL] [Abstract][Full Text] [Related]
15. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L
Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.
Levine AJ; Phipps AI; Baron JA; Buchanan DD; Ahnen DJ; Cohen SA; Lindor NM; Newcomb PA; Rosty C; Haile RW; Laird PW; Weisenberger DJ
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):68-75. PubMed ID: 26512054
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
[TBL] [Abstract][Full Text] [Related]
18. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer.
Wu F; Lu M; Qu L; Li DQ; Hu CH
Int J Clin Exp Pathol; 2015; 8(5):5457-63. PubMed ID: 26191250
[TBL] [Abstract][Full Text] [Related]
20. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
